These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24433453)

  • 21. ALG12-CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant.
    de la Morena-Barrio ME; Sabater M; de la Morena-Barrio B; Ruhaak RL; Miñano A; Padilla J; Toderici M; Roldán V; Gimeno JR; Vicente V; Corral J
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1304. PubMed ID: 32530140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations.
    Erlandson A; Bjursell C; Stibler H; Kristiansson B; Wahlström J; Martinsson T
    Hum Genet; 2001 May; 108(5):359-67. PubMed ID: 11409861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A compound heterozygous mutation in DPAGT1 results in a congenital disorder of glycosylation with a relatively mild phenotype.
    Iqbal Z; Shahzad M; Vissers LE; van Scherpenzeel M; Gilissen C; Razzaq A; Zahoor MY; Khan SN; Kleefstra T; Veltman JA; de Brouwer AP; Lefeber DJ; van Bokhoven H; Riazuddin S
    Eur J Hum Genet; 2013 Aug; 21(8):844-9. PubMed ID: 23249953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal glycosylation screening does not rule out SRD5A3-CDG.
    Mohamed M; Cantagrel V; Al-Gazali L; Wevers RA; Lefeber DJ; Morava E
    Eur J Hum Genet; 2011 Oct; 19(10):1019. PubMed ID: 21750573
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical, biochemical and molecular phenotype of congenital disorders of glycosylation: long-term follow-up.
    Bogdańska A; Lipiński P; Szymańska-Rożek P; Jezela-Stanek A; Rokicki D; Socha P; Tylki-Szymańska A
    Orphanet J Rare Dis; 2021 Jan; 16(1):17. PubMed ID: 33407696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) initially diagnosed as ALG6-CDG: Functional evidence for benignity of the ALG6 c.391T>C (p.Tyr131His) variant and further expanding the BBSOAS phenotype.
    Starosta RT; Tarnowski J; Vairo FPE; Raymond K; Preston G; Morava E
    Eur J Med Genet; 2020 Jul; 63(7):103941. PubMed ID: 32407885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder.
    Cantagrel V; Lefeber DJ; Ng BG; Guan Z; Silhavy JL; Bielas SL; Lehle L; Hombauer H; Adamowicz M; Swiezewska E; De Brouwer AP; Blümel P; Sykut-Cegielska J; Houliston S; Swistun D; Ali BR; Dobyns WB; Babovic-Vuksanovic D; van Bokhoven H; Wevers RA; Raetz CR; Freeze HH; Morava E; Al-Gazali L; Gleeson JG
    Cell; 2010 Jul; 142(2):203-17. PubMed ID: 20637498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligosaccharyltransferase complex-congenital disorders of glycosylation: A novel congenital disorder of glycosylation.
    Bryant EM; Millichap JJ; Spinelli E; Calhoun JD; Miller C; Giannelli J; Wolak J; Sanders V; Carvill GL; Charrow J
    Am J Med Genet A; 2020 Jun; 182(6):1460-1465. PubMed ID: 32267060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-glycome analysis detects dysglycosylation missed by conventional methods in SLC39A8 deficiency.
    Park JH; Mealer RG; Elias AF; Hoffmann S; Grüneberg M; Biskup S; Fobker M; Haven J; Mangels U; Reunert J; Rust S; Schoof J; Schwanke C; Smoller JW; Cummings RD; Marquardt T
    J Inherit Metab Dis; 2020 Nov; 43(6):1370-1381. PubMed ID: 32852845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis.
    Wilson MP; Kentache T; Althoff CR; Schulz C; de Bettignies G; Mateu Cabrera G; Cimbalistiene L; Burnyte B; Yoon G; Costain G; Vuillaumier-Barrot S; Cheillan D; Rymen D; Rychtarova L; Hansikova H; Bury M; Dewulf JP; Caligiore F; Jaeken J; Cantagrel V; Van Schaftingen E; Matthijs G; Foulquier F; Bommer GT
    Cell; 2024 Jul; 187(14):3585-3601.e22. PubMed ID: 38821050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Congenital Disorders of Glycosylation in Childhood Epilepsy and Effects of Anti-Epileptic Drugs on the Transferrin Isoelectric Focusing Test.
    Silver G; Bahl S; Cordeiro D; Thakral A; Athey T; Mercimek-Andrews S
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DDOST mutations identified by whole-exome sequencing are implicated in congenital disorders of glycosylation.
    Jones MA; Ng BG; Bhide S; Chin E; Rhodenizer D; He P; Losfeld ME; He M; Raymond K; Berry G; Freeze HH; Hegde MR
    Am J Hum Genet; 2012 Feb; 90(2):363-8. PubMed ID: 22305527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALG3-CDG (CDG-Id): clinical, biochemical and molecular findings in two siblings.
    Riess S; Reddihough DS; Howell KB; Dagia C; Jaeken J; Matthijs G; Yaplito-Lee J
    Mol Genet Metab; 2013; 110(1-2):170-5. PubMed ID: 23791010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical phenotype correlates to glycoprotein phenotype in a sib pair with CDG-Ia.
    Barone R; Sturiale L; Sofia V; Ignoto A; Fiumara A; Sorge G; Garozzo D; Zappia M
    Am J Med Genet A; 2008 Aug; 146A(16):2103-8. PubMed ID: 18629883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features.
    Weinstein M; Schollen E; Matthijs G; Neupert C; Hennet T; Grubenmann CE; Frank CG; Aebi M; Clarke JT; Griffiths A; Seargeant L; Poplawski N
    Am J Med Genet A; 2005 Jul; 136(2):194-7. PubMed ID: 15945070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAN1B-CDG: Novel variants with a distinct phenotype and review of literature.
    Balasubramanian M; Johnson DS;
    Eur J Med Genet; 2019 Feb; 62(2):109-114. PubMed ID: 29908352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further delineation of COG8-CDG: A case with novel compound heterozygous mutations diagnosed by targeted exome sequencing.
    Yang A; Cho SY; Jang JH; Kim J; Kim SZ; Lee BH; Yoo HW; Jin DK
    Clin Chim Acta; 2017 Aug; 471():191-195. PubMed ID: 28619360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation.
    Sabry S; Eissa NR; Zaki MS
    BMC Res Notes; 2023 Apr; 16(1):53. PubMed ID: 37069668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency.
    Westphal V; Kjaergaard S; Schollen E; Martens K; Grunewald S; Schwartz M; Matthijs G; Freeze HH
    Hum Mol Genet; 2002 Mar; 11(5):599-604. PubMed ID: 11875054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease.
    Würde AE; Reunert J; Rust S; Hertzberg C; Haverkämper S; Nürnberg G; Nürnberg P; Lehle L; Rossi R; Marquardt T
    Mol Genet Metab; 2012 Apr; 105(4):634-41. PubMed ID: 22304930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.